<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/A0A585E0-6B0D-4643-A3A6-47943B4CBFEF"><gtr:id>A0A585E0-6B0D-4643-A3A6-47943B4CBFEF</gtr:id><gtr:name>University of Liverpool</gtr:name><gtr:address><gtr:line1>Senate House</gtr:line1><gtr:line2>Abercromby Square</gtr:line2><gtr:line4>Liverpool</gtr:line4><gtr:postCode>L69 3BX</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/19185705-3FB8-4C9C-B8F4-D5D7EA64F57F"><gtr:id>19185705-3FB8-4C9C-B8F4-D5D7EA64F57F</gtr:id><gtr:name>National Center for Biotechnology Information (NCBI)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/11E604AE-3915-4673-AEA6-852F7D6BFFD8"><gtr:id>11E604AE-3915-4673-AEA6-852F7D6BFFD8</gtr:id><gtr:name>Wellcome Trust</gtr:name><gtr:address><gtr:line1>183 EUSTON ROAD</gtr:line1><gtr:city>LONDON</gtr:city><gtr:postCode>NW1  2BE</gtr:postCode><gtr:region>London</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/0407B94D-DABF-4B46-B5F0-2CBDC1C63C67"><gtr:id>0407B94D-DABF-4B46-B5F0-2CBDC1C63C67</gtr:id><gtr:name>national Institute on Aging</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:department>Institute of Neurology</gtr:department><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/A0A585E0-6B0D-4643-A3A6-47943B4CBFEF"><gtr:id>A0A585E0-6B0D-4643-A3A6-47943B4CBFEF</gtr:id><gtr:name>University of Liverpool</gtr:name><gtr:address><gtr:line1>Senate House</gtr:line1><gtr:line2>Abercromby Square</gtr:line2><gtr:line4>Liverpool</gtr:line4><gtr:postCode>L69 3BX</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/19185705-3FB8-4C9C-B8F4-D5D7EA64F57F"><gtr:id>19185705-3FB8-4C9C-B8F4-D5D7EA64F57F</gtr:id><gtr:name>National Center for Biotechnology Information (NCBI)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/11E604AE-3915-4673-AEA6-852F7D6BFFD8"><gtr:id>11E604AE-3915-4673-AEA6-852F7D6BFFD8</gtr:id><gtr:name>Wellcome Trust</gtr:name><gtr:address><gtr:line1>183 EUSTON ROAD</gtr:line1><gtr:city>LONDON</gtr:city><gtr:postCode>NW1  2BE</gtr:postCode><gtr:region>London</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/0407B94D-DABF-4B46-B5F0-2CBDC1C63C67"><gtr:id>0407B94D-DABF-4B46-B5F0-2CBDC1C63C67</gtr:id><gtr:name>national Institute on Aging</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/9D5EE642-D3A9-47CF-AAAD-C20257327A54"><gtr:id>9D5EE642-D3A9-47CF-AAAD-C20257327A54</gtr:id><gtr:firstName>Michael</gtr:firstName><gtr:surname>Weale</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/C98B6651-B765-4F6B-82FF-E771DAAC4DE0"><gtr:id>C98B6651-B765-4F6B-82FF-E771DAAC4DE0</gtr:id><gtr:firstName>Daniah</gtr:firstName><gtr:surname>Trabzuni</gtr:surname><gtr:roles><gtr:role><gtr:name>RESEARCHER</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/BEF050EE-F7BD-416E-B0A3-5886681BAD7A"><gtr:id>BEF050EE-F7BD-416E-B0A3-5886681BAD7A</gtr:id><gtr:firstName>Adaikalavan</gtr:firstName><gtr:surname>Ramasamy</gtr:surname><gtr:roles><gtr:role><gtr:name>RESEARCHER</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/2761A603-5EF4-4006-8C7C-FBD7F3D90FC5"><gtr:id>2761A603-5EF4-4006-8C7C-FBD7F3D90FC5</gtr:id><gtr:firstName>John</gtr:firstName><gtr:surname>Hardy</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/970F19FA-3F65-4E76-830D-9A352A0B0E99"><gtr:id>970F19FA-3F65-4E76-830D-9A352A0B0E99</gtr:id><gtr:firstName>Mar</gtr:firstName><gtr:surname>Matarin</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/2FD74E02-67E7-4F8D-B2D2-C3599AF01051"><gtr:id>2FD74E02-67E7-4F8D-B2D2-C3599AF01051</gtr:id><gtr:firstName>Mina</gtr:firstName><gtr:surname>Ryten</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MR%2FK01417X%2F1"><gtr:id>FEE7B7F3-B492-400D-8BD2-D5381D7568CE</gtr:id><gtr:title>Using genetic variability in whole transcriptome expression in cells and tissues to understand the pathogenesis of Parkinson's and Alzheimer's disease</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>MR/K01417X/1</gtr:grantReference><gtr:abstractText>Parkinson's and Alzheimer's disease (PD &amp;amp; AD) are common diseases that affect the brain, causing certain cells to die. When these cells are lost people experience, amongst other problems, difficulty remembering recent events in the case of AD and difficulties moving in the case of PD. At the moment these diseases affect over 1 million people in the United Kingdom with a devastating impact on patients and their families. Since both these diseases become more common with age, the number of sufferers is likely to increase as the number of elderly people rises in the UK. Unfortunately, at the moment we know relatively little about why certain people suffer from these diseases and until we do it is hard for researchers and doctors to develop effective treatments. 
In the past 3 years scientists have been able to show that some individuals have common changes in their DNA (the instruction manual for all the building blocks needed to make the human body) that put them at higher risk of developing these conditions. Although this has been an amazing step forward, it has not been easy for scientists to understand how these changes in the DNA, termed genetic risk factors, act to help cause disease. Many people believe that one way in which these genetic risk factors might cause disease is by changing how much or the way in which particular genes (the basic building blocks) are expressed in brain cells. In order to check this, researchers need to make measurements about the genetic variation an individual carries and link this information to the genes they express in their cells.
Although this type of investigation is particularly challenging for diseases that affect the brain, it is possible and meeting those challenges is the aim of this project. One of the difficulties is accurately measuring the amount of the gene expressed in the right cells in the brain. The brain is extremely complex and even within a single region there are many different types of cells. We will address this problem by making use of a technique called laser capture microdissection to obtain pure collections of cells from brain regions relevant to PD and AD. In this technique, using very thin slices of the human brain tissue, we shoot out just the cells we are interested in collecting with a high power laser and then extract the RNA (the gene copies) from the pellets we shoot out. Another advance is the advent of new technology for measuring all the genes expressed in a single cell type or tissue sample. This technology is called &amp;quot;RNA-seq&amp;quot; or &amp;quot;whole transcriptome sequencing&amp;quot; and it allows us to measure all kinds of gene product from any gene. It also allows us to measure the relative quantities of alternative versions of the same gene, and to measure these quantities in such a way that the influence of genetic risk factors can be more sensitively detected by directly comparing the relative product quantities in individuals who happen to have both a &amp;quot;good&amp;quot; and a &amp;quot;bad&amp;quot; copy of a given genetic variant. 
We believe that we are in an ideal position to complete this project and so add important insights to the understanding of PD and AD. We already have many of the RNA samples needed to perform this study and while some new RNA samples will be created during the project, through our close collaboration with the MRC Sudden Death Brain and Tissue Bank in Edinburgh we have the brain samples needed to do this (all of which have been donated for research). We have also already carried out extensive analysis of DNA from these samples, which means that the new information we generate during this grant can be quickly and cost-effectively added to existing sources of data in order to progress this research. As a final benefit, all the data we will generate on the human brain will be made publically available so that other scientists interested in understanding how the human brain works in health and disease can use this information.</gtr:abstractText><gtr:technicalSummary>The aim of this study is to determine the effect of genetic risk factors on whole transcriptome expression in brain regions and cell types most vulnerable to Parkinson's and Alzheimer's disease (PD and AD) in order to understand the pathogenic processes underlying these conditions. This project is inspired by the recent discovery of 15 new genetic risk variants for PD and 13 new loci for AD. However, knowing the genomic position of risk variants is not equivalent to knowing how they act in terms of the underlying molecular processes or where they act in terms of the regional or cellular location. We aim to address both these issues. Using control post-mortem human brain tissue originating from 150 individuals, we will use expression quantitative trait locus (eQTL) mapping and allele-specific expression (ASE) analysis to identify loci that both change disease risk and regulate the expression of specific gene transcripts within specific tissues/cells. We will conduct these studies within the tissues and cells most relevant to PD and AD, namely the substantia nigra, hippocampus, temporal cortex, dopaminergic neurons, CA1 neurons, pyramidal neurons and astrocytes. Existing exome sequencing and SNP array data will be combined with whole transcriptome RNA sequencing data generated on the Illumina HiSeq2000 platform for downstream analysis. These two types of information - genetic variation and transcript expression - will be used for eQTL mapping in tissues and ASE analysis in cells. In both cases the eQTLs identified will be annotated for disease-relevance in the first instance. All the data generated by this project will be publicly released as both raw data files for re-analysis and processed information suitable for non-expert users through NCBI's Gene Expression Omnibus repository and Phenotype-Genotype Integrator sites. Thus, we will generate novel disease-relevant findings and provide the neuroscience community with a world-class resource.</gtr:technicalSummary><gtr:potentialImpactText>The goal of this work is to develop comprehensive databases which allow the interpretation of the genome wide association studies (GWAS) for the two most common neurodegenerative diseases, Parkinson's and Alzheimer's disease (PD and AD). In this way, we will improve our understanding of the pathogenic processes underlying these diseases and in the long term improve the diagnosis and treatment of patients struggling to cope with these debilitating diseases. Reaching this goal will require many intermediate steps and we describe who we envisage using our research findings and how this data will help them.

Researchers interested in the follow up of GWAS data: This study was designed to improve our understanding of the molecular mode of action and cellular location in which genetic risk variants for PD and AD act. Therefore, the most obvious users of our data are the original AD and PD consortia. However, the results of this study will also be useful for the interpretation of GWAS for other neurological and psychiatric disorders, making it relevant to researchers interested in the results of GWAS in frontotemporal dementia, epilepsy, depression and schizophrenia to name a few. Since we are publicly releasing all findings through the NCBI's searchable database, Phenotype-Genotype Integrator, we envisage other less specialist researchers also accessing and using the data. These individuals include clinicians, epidemiologists and drug companies interested in following up GWAS hits for clinical trial design or biomarker development.

Researchers interested in the creation and use of in vitro model systems: The cell-specific whole transcriptome sequencing data produced in this project will be a baseline for the detailed molecular assessment of stem cell-based disease models. We will work collaboratively with researchers in the University of Edinburgh (Dr. Kunath &amp;amp; Dr. Chandran) and Cambridge University (Dr. Livesey) to identify the strengths and weaknesses of existing cell models and work to improve the accuracy of these systems. Thus, we will contribute to the development of new research tools for use by the neuroscience research community within universities and in the private setting. 

Basic neurobiologists: The large gene expression data sets we are producing will provide insights into other aspects of basic neurobiology. For example, it will be of value to those researchers interested in analysing sex differences in transcript expression. Using this data it will be possible to improve our understanding of the basis of well recognised differences in the incidence, presentation and response to treatment of many neurological disorders. This could in turn contribute to the drive towards individualised patient assessment and care. 

Bioinformaticians &amp;amp; statistical geneticists: The raw genotyping, exome and RNA sequencing data will be used by statistical genetics and bioinformatics wishing to test and develop new statistical and analytical methods. In particular, the existence of paired exome sequencing and SNP array data will allow researchers to objectively test and improve methods for the imputation of genetic data. Therefore, we will directly contribute to one of the MRC's stated aims, the training of more researchers and clinicians in bioinformatics.

Charities &amp;amp; patient groups: The discovery of genetic risk variants for PD and AD represent one of the most significant steps forward in the understanding of these diseases in the last 10 years. Therefore, they are hugely important to patients and carers who desperately want to see progress in the diagnosis and treatment of their diseases. From our own experience of hosting visits for Parkinson's Disease UK, Alzheimer's Research UK and the Michael J Fox Foundation, we recognise the importance of engaging with patients and communicating the findings generated from our research in order to maintain hope, create novel resources and improve the uptake of clinical trials.</gtr:potentialImpactText><gtr:fund><gtr:end>2016-09-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2013-05-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>1068270</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Institute of Neurology</gtr:department><gtr:description>Genetic risk variants for mesio-temporal lobe epilepsy</gtr:description><gtr:id>FBA8866B-0159-44D8-808D-2592F46FB70C</gtr:id><gtr:impact>There is presently a paper in submission with Nature Genetics.</gtr:impact><gtr:outcomeId>UNQJzq25XTV-1</gtr:outcomeId><gtr:partnerContribution>They have identified risk SNPs for mesio-temporal lobe epilepsy.</gtr:partnerContribution><gtr:piContribution>We have provided regional eQTL data and total RNA extracted from human brain tissue originating from neurologically normal individuals.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Wellcome Trust</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Multiple Tissue Human Expression Resource (MuTHER) consortium</gtr:department><gtr:description>Age-related changes in gene expression in human brain</gtr:description><gtr:id>26286133-5D5F-49FF-9F96-53CD5CA461C9</gtr:id><gtr:impact>There is a paper in submission with Genome Research</gtr:impact><gtr:outcomeId>NVUBbFYrLWS-1</gtr:outcomeId><gtr:partnerContribution>They have provided gene expression data relating to multiple other human tissues.</gtr:partnerContribution><gtr:piContribution>We have provided gene expression data on human brain.</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Edinburgh</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC Centre for Regenerative Medicine</gtr:department><gtr:description>Whole genome expression in iPS-derived neurons in health and disease</gtr:description><gtr:id>FD8C9FE4-2F64-4459-B0BD-48C508F0DF04</gtr:id><gtr:impact>This collaboration has resulted in a publication in Nature Communications and also prompted the submission of a successful project grant to the Alzheimer's Research Trust (&amp;pound;30,000).

This is a project using the skills and knowledge of specialist cell biologists with my own technical skills in expression analysis.</gtr:impact><gtr:outcomeId>hqscwYa4zxT-1</gtr:outcomeId><gtr:partnerContribution>It has resulted in the provision of unique samples for the investigation of the impact of specific genetic mutations known to cause Parkinson's Disease on gene expression.</gtr:partnerContribution><gtr:piContribution>We have performed the analysis of geen expression and splicing in these samples.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>National Institute on Aging</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Laboratory of Neurogenetics</gtr:department><gtr:description>Whole genome expression database</gtr:description><gtr:id>E3E82082-70A1-4FCD-8D1D-3ABB27F5A85A</gtr:id><gtr:impact>Just search Ryten plus Singleton on pubmed
These are the current PMID
23223016, 23177596, 22892372 , 22777693, 22723018, 22433082, 21738488 , 21292315</gtr:impact><gtr:outcomeId>dqs5q7xdifx-1</gtr:outcomeId><gtr:partnerContribution>We worked with our Us collaborators on this project (Singleton/Cookson): about half the work each</gtr:partnerContribution><gtr:piContribution>We are just abouhttp://bit.ly/braineac (ignore certificate warning)
username: UKBEC
password: BraineacNOW
t to relase this database to the general public</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>National Center for Biotechnology Information (NCBI)</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>eQTL analysis in control human cerebellum and frontal cortex</gtr:description><gtr:id>3BB143D5-8CC4-4797-9A95-FE246AED63A2</gtr:id><gtr:impact>We have a publication in submission as a direct result of this study.</gtr:impact><gtr:outcomeId>dotKxjojvUf-1</gtr:outcomeId><gtr:partnerContribution>This collaboration has allowed us to increase the power of our study by increasing the n number and has provided us with technical expertise regarding the analysis of eQTL data.</gtr:partnerContribution><gtr:piContribution>We have provided a considerable amount of processed gene expression data.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Edinburgh</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Centre for Clinical Brain Sciences (CCBS)</gtr:department><gtr:description>Whole genome expression analysis for the assessment of hESC-derived neuronal maturation</gtr:description><gtr:id>B97D557F-970D-4E53-B277-BD9D9C76C0AB</gtr:id><gtr:impact>We currently have a paper in submission to Human Molecular Genetics.

This collaboration is multidisciplinary with specialist cell and developmental biologists.</gtr:impact><gtr:outcomeId>edhrXQCuNXQ-1</gtr:outcomeId><gtr:partnerContribution>They have provided samples of hESCs, neural precursors and hESc-derived neurons. They have also provided expertise on the process of neural differentiation.</gtr:partnerContribution><gtr:piContribution>I have performed the expression and splicing analysis of these samples.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Liverpool</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>PARK7 gene structure and expression</gtr:description><gtr:id>A0F45017-F3A6-47EC-A360-063F0D4582AD</gtr:id><gtr:impact>Manuscript in preparation</gtr:impact><gtr:outcomeId>YMZei2BvzgC-1</gtr:outcomeId><gtr:partnerContribution>Expertise regarding the structure and function of PARK7</gtr:partnerContribution><gtr:piContribution>Expression and RNAseq data and data interpretation relating to PARK7 expression in human brain</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>National Center for Biotechnology Information (NCBI)</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>eQTLs with relevance to brain anatomy as measured by MRI</gtr:description><gtr:id>2D6B2C21-D82D-47A2-9261-B758D5A62662</gtr:id><gtr:impact>This collaboration has resulted in the publication of a Nature Genetics paper.</gtr:impact><gtr:outcomeId>e4Dcb49LUmV-1</gtr:outcomeId><gtr:partnerContribution>The ENIGMA consortium have used MRI scanning and SNP genotyping to identify SNPs that relate to hippocampal volume among other measurements.</gtr:partnerContribution><gtr:piContribution>We have provided region-specific eQTL data.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Edinburgh</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Neuropathology Unit</gtr:department><gtr:description>Collection and analysis of control human post-mortem brain tissue</gtr:description><gtr:id>DFAE40CC-E42A-4054-868D-7CA023F6EDD5</gtr:id><gtr:impact>This collaboration has allowed us to build a database of exon-specific gene expression in multiple human brain regions.</gtr:impact><gtr:outcomeId>NHHap7DWLSC-1</gtr:outcomeId><gtr:partnerContribution>This collaboration has allowed to collect high quality control human brain tissue for analysis.</gtr:partnerContribution><gtr:piContribution>We have supplied our collaborators with information regarding the degree of RNA preservation within banked control human brain tissue.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Talk for the Cardiff Gene Park to sixthformers</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>8F3AB4D2-7390-4939-BF08-A8B600B08E11</gtr:id><gtr:impact>The talk sparked discussion following the event

No notable impact yet</gtr:impact><gtr:outcomeId>548a04fce786c1.28005447</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Workshop on Alzheimer's Disease and Related Disorders, FBRI Meeting, Kronberg, Germany</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>2368B57B-2F86-416B-8CEC-C2734C6042DA</gtr:id><gtr:impact>Prof Hardy led the workshop. Exchange of ideas and information.

Excellent feedback. Participants reported being pleased with the intellectual stimulation.</gtr:impact><gtr:outcomeId>565c6a9ab9e6e6.04923589</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>workshop facilitator</gtr:presentationType><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Website - SAFARI</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>BA06E74F-D8A8-49C8-92BB-986525403E93</gtr:id><gtr:impact>The report has sparked interest in our data set and resources

I have been e-mailed for specific data</gtr:impact><gtr:outcomeId>546d10d783a1d1.64818483</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Website - Alzforum</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>730FEE11-BFF9-4F8C-B352-8D6B5BF369B1</gtr:id><gtr:impact>Interview has sparked online comments

Requests for data sharing</gtr:impact><gtr:outcomeId>546d1150683ce4.51858960</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>1000000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Project Grant</gtr:description><gtr:end>2013-03-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>A847B240-B6D2-4FA8-8005-52AB7BEFA45C</gtr:id><gtr:outcomeId>BUAVcrvWKEE0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-03-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>530000</gtr:amountPounds><gtr:country>Global</gtr:country><gtr:currCode>EUR</gtr:currCode><gtr:currCountryCode>Austria</gtr:currCountryCode><gtr:currLang>de_AT</gtr:currLang><gtr:description>EU Joint Programme Grant</gtr:description><gtr:end>2017-01-02</gtr:end><gtr:fundingOrg>JPND Research</gtr:fundingOrg><gtr:id>8FDF840A-A45F-41D7-BF66-21CE1D830671</gtr:id><gtr:outcomeId>G68VJ9iS6KG</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>200000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Wellcome Trust Bloomsbury Centre</gtr:department><gtr:description>Wellcome Biomedical Resource Grant</gtr:description><gtr:end>2019-10-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>99920C33-BBE8-493E-A157-698E9C9E4A63</gtr:id><gtr:outcomeId>58c810623ed3f0.48950269</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1300000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Project Grant</gtr:description><gtr:end>2016-03-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>85387F83-E4AC-4302-AD61-C923B8466F74</gtr:id><gtr:outcomeId>Pt8SwGQAPXr</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-03-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Joint Lead for Bioinformatics in Neurology GeCIP</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>8DBB1A3C-DBF9-4698-9BB2-703E6527B1B2</gtr:id><gtr:outcomeId>58c812127d08a5.73429239</gtr:outcomeId><gtr:type>Membership of a guideline committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Invited to attend a workshop on skills development for the NIHR</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>81355260-AB8D-495C-B846-75CD5A911CF8</gtr:id><gtr:outcomeId>56e1ebdb2bcf37.27469861</gtr:outcomeId><gtr:type>Participation in a national consultation</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Attachment with Genomics England</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>8EDD45DF-0F55-4E67-A9A3-B1E80700F9BB</gtr:id><gtr:outcomeId>546d11da6c6a10.20220080</gtr:outcomeId><gtr:type>Influenced training of practitioners or researchers</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>House of Lords visit</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>8E61EDF1-3092-4E98-8E73-203E96A98EC7</gtr:id><gtr:impact>Lobbying for more funding for movement disorder diseases</gtr:impact><gtr:outcomeId>fJErZKWEwaJ</gtr:outcomeId><gtr:type>Gave evidence to a government review</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>I contributed to the HEXdatabase which provides information on genetic variation in individuals with no evidence of a neurological disorder.</gtr:description><gtr:id>4FBAC4B6-37E8-4D1E-8582-25425B9EF83F</gtr:id><gtr:impact>This tool will be released on the Alzform website.</gtr:impact><gtr:outcomeId>56e1ec9b657a06.22873090</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Database on genetic variation in neurologically normal individuals over the age of 60 years old</gtr:title><gtr:type>Biological samples</gtr:type><gtr:yearFirstProvided>2016</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>We have created a web-based tool to allow researchers to access the eQTL data we have generated and expression profiles in human brain.</gtr:description><gtr:id>17AF6692-D37F-4C4B-B94C-742D13504B4F</gtr:id><gtr:impact>This is presently being used by groups within KCL and UCL to follow up GWAS results.</gtr:impact><gtr:outcomeId>MNzVy3LggJx</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>A web-based tool for eQTL analysis and expression profiles</gtr:title><gtr:type>Biological samples</gtr:type><gtr:yearFirstProvided>2013</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Gene expression database.

http://caprica.genetics.kcl.ac.uk:51519/BRAINEAC/</gtr:description><gtr:id>23B0BF4D-D69D-4CA4-B3B9-4620ADBD9187</gtr:id><gtr:impact>It has been accessed several thousand times and data from it incorporated into at least 100 publications</gtr:impact><gtr:outcomeId>Wb8yNb7u8e4</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Human genome expression database</gtr:title><gtr:type>Model of mechanisms or symptoms - in vitro</gtr:type><gtr:url>http://smarturl.it/braineac</gtr:url><gtr:yearFirstProvided>2010</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>This is a database of exon-specific gene expression generated from over 800 RNA samples extracted from post-mortem human brain tissue.</gtr:description><gtr:id>82E1DE7D-16B8-49C6-B6FC-30EACA3DC090</gtr:id><gtr:impact>This collection of data when released will provide researchers working in the field of neuroscience comprehensive imformation on the expression of all genes within multiple human brain regions.</gtr:impact><gtr:outcomeId>jPMm9wQtVgW</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Genome-wide gene expression in 10 human brain regions</gtr:title><gtr:type>Biological samples</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Stem cell biobank. Freely available.</gtr:description><gtr:id>38E9EC2D-20D0-4D4A-9E43-7EE92453C7E4</gtr:id><gtr:impact>This has been a successful application and many drug companies are using stem cell lines supplied by our group</gtr:impact><gtr:outcomeId>mojiZV314C4</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>StemBANCC</gtr:title><gtr:type>Cell line</gtr:type><gtr:url>http://stembancc.org</gtr:url><gtr:yearFirstProvided>2012</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>This is a web-based tool to allow users to check whether reported eQTLs may be due to systematic errors arising from the presence of polymorphisms within expression microarray probes.</gtr:description><gtr:id>20A543F7-A922-47CA-9191-E7E69D73B672</gtr:id><gtr:impact>This is currently being used by our collaborators based in the NIH, but will soon be made publicly available. It has resulted in the identification of a significant number of false positive results.</gtr:impact><gtr:outcomeId>dAXpZZxXUXB</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>A web-based tool  for quality control of eQTL data</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:yearFirstProvided>2012</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>DD91629A-0DD5-4884-A644-57155102898A</gtr:id><gtr:title>Genetic variability in the regulation of gene expression in ten regions of the human brain.</gtr:title><gtr:parentPublicationTitle>Nature neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/52571622ddf586543c15906e6485b96b"><gtr:id>52571622ddf586543c15906e6485b96b</gtr:id><gtr:otherNames>Ramasamy A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1097-6256</gtr:issn><gtr:outcomeId>546d082e9b2a77.57891978</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5F71ED47-999C-4C0E-A91C-6A9EE551B208</gtr:id><gtr:title>Genetic analysis of disease in the era of whole genome analysis and public databases.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8cdc37128f45833332c0ee457dd6ee0e"><gtr:id>8cdc37128f45833332c0ee457dd6ee0e</gtr:id><gtr:otherNames>Hardy J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn><gtr:outcomeId>pm_16043_23_22330098</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>42601407-D924-4C54-A2BD-7F3BB9EA6B4D</gtr:id><gtr:title>The phenotypic and molecular spectrum of PEHO syndrome and PEHO-like disorders.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c12954aa30a8fba72f3439d776bda00b"><gtr:id>c12954aa30a8fba72f3439d776bda00b</gtr:id><gtr:otherNames>Salpietro V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>5aa460bbca1733.13124838</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BCC8CCEF-8F99-4BEB-BFB8-7F08BF2A8212</gtr:id><gtr:title>Genomics implicates adaptive and innate immunity in Alzheimer's and Parkinson's diseases.</gtr:title><gtr:parentPublicationTitle>Annals of clinical and translational neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c20407c840fc3c52f1897ad927fd9e33"><gtr:id>c20407c840fc3c52f1897ad927fd9e33</gtr:id><gtr:otherNames>Gagliano SA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2328-9503</gtr:issn><gtr:outcomeId>5aa460be09dfd8.96735701</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>31EA39C7-4578-4E9C-9A47-EF22582DC9FD</gtr:id><gtr:title>Microduplications at the pseudoautosomal SHOX locus in autism spectrum disorders and related neurodevelopmental conditions.</gtr:title><gtr:parentPublicationTitle>Journal of medical genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/26108b7cf1d7d21c369626ecf0bd2ec3"><gtr:id>26108b7cf1d7d21c369626ecf0bd2ec3</gtr:id><gtr:otherNames>Tropeano M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0022-2593</gtr:issn><gtr:outcomeId>5aa460be4ce500.54661518</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>303018AF-7BB4-4002-9567-5CDD15BE5420</gtr:id><gtr:title>The ENIGMA Consortium: large-scale collaborative analyses of neuroimaging and genetic data.</gtr:title><gtr:parentPublicationTitle>Brain imaging and behavior</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/545bcb850f5bee6c4b4bb77b4df4cf03"><gtr:id>545bcb850f5bee6c4b4bb77b4df4cf03</gtr:id><gtr:otherNames>Thompson PM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1931-7557</gtr:issn><gtr:outcomeId>5464d37db6f000.58283245</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2C3A2ABF-3991-484E-A924-C3D5D844D410</gtr:id><gtr:title>Whole genome expression as a quantitative trait.</gtr:title><gtr:parentPublicationTitle>Biochemical Society transactions</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8cdc37128f45833332c0ee457dd6ee0e"><gtr:id>8cdc37128f45833332c0ee457dd6ee0e</gtr:id><gtr:otherNames>Hardy J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0300-5127</gtr:issn><gtr:outcomeId>oCmtYyuzfgZ</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>596A5485-9B00-4EDF-B296-4EF68C1BAF9E</gtr:id><gtr:title>Major Shifts in Glial Regional Identity Are a Transcriptional Hallmark of Human Brain Aging.</gtr:title><gtr:parentPublicationTitle>Cell reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a171f3d658cd96b7ebe3bcec8dea503c"><gtr:id>a171f3d658cd96b7ebe3bcec8dea503c</gtr:id><gtr:otherNames>Soreq L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:outcomeId>58c7ccc56316a4.78832576</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>12B77043-9D19-46A7-A30B-2D36D6CDE0DA</gtr:id><gtr:title>CSF biomarking for diagnosis and treatment assessment in neurodegeneration.</gtr:title><gtr:parentPublicationTitle>Journal of neurochemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8cdc37128f45833332c0ee457dd6ee0e"><gtr:id>8cdc37128f45833332c0ee457dd6ee0e</gtr:id><gtr:otherNames>Hardy J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0022-3042</gtr:issn><gtr:outcomeId>pm_16043_23_22994375</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A5AD9815-9C13-49EE-95AA-AB8711212128</gtr:id><gtr:title>Functional characterization of three single-nucleotide polymorphisms present in the human APOE promoter sequence: Differential effects in neuronal cells and on DNA-protein interactions.</gtr:title><gtr:parentPublicationTitle>American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/86f06eda9bad27036b22a55ef7699725"><gtr:id>86f06eda9bad27036b22a55ef7699725</gtr:id><gtr:otherNames>Maloney B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1552-4841</gtr:issn><gtr:outcomeId>1D27D05F961</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9FE93FAF-39B2-4A0F-8ED6-D82814F47934</gtr:id><gtr:title>Sequencing analysis of the ITPR1 gene in a pure autosomal dominant spinocerebellar ataxia series.</gtr:title><gtr:parentPublicationTitle>Movement disorders : official journal of the Movement Disorder Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/673eb3a354040dbcb56dbe98ec677ebe"><gtr:id>673eb3a354040dbcb56dbe98ec677ebe</gtr:id><gtr:otherNames>van de Leemput J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0885-3185</gtr:issn><gtr:outcomeId>pm-16043-20437544</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>890BF48A-950A-4946-B2DE-C520F8BBA3A3</gtr:id><gtr:title>Genome wide assessment of young onset Parkinson's disease from Finland.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5fa0a98b877dd2fe06320fd79e75f4c4"><gtr:id>5fa0a98b877dd2fe06320fd79e75f4c4</gtr:id><gtr:otherNames>Hernandez DG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_16043_23_22911860</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C54F37FA-9A75-47F7-A79E-7E0DC7054A80</gtr:id><gtr:title>Imputation of sequence variants for identification of genetic risks for Parkinson's disease: a meta-analysis of genome-wide association studies.</gtr:title><gtr:parentPublicationTitle>Lancet (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1e2d0f395414b93ca8e16b698d9d8d12"><gtr:id>1e2d0f395414b93ca8e16b698d9d8d12</gtr:id><gtr:otherNames>International Parkinson Disease Genomics Consortium</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0140-6736</gtr:issn><gtr:outcomeId>bWPLHXWMmMD</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>883E0D3C-FCA8-4618-AB02-13A737AE4D1C</gtr:id><gtr:title>Integration of GWAS SNPs and tissue specific expression profiling reveal discrete eQTLs for human traits in blood and brain.</gtr:title><gtr:parentPublicationTitle>Neurobiology of disease</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5fa0a98b877dd2fe06320fd79e75f4c4"><gtr:id>5fa0a98b877dd2fe06320fd79e75f4c4</gtr:id><gtr:otherNames>Hernandez DG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0969-9961</gtr:issn><gtr:outcomeId>pm_16043_23_22433082</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D9B32C0B-A983-401D-9FF1-50B4E0505232</gtr:id><gtr:title>Sample tracking and use in published genome-wide association studies.</gtr:title><gtr:parentPublicationTitle>Archives of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8cdc37128f45833332c0ee457dd6ee0e"><gtr:id>8cdc37128f45833332c0ee457dd6ee0e</gtr:id><gtr:otherNames>Hardy J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0003-9942</gtr:issn><gtr:outcomeId>pm-16043-20937956</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A3E121FB-A480-4363-989B-2C0714694C2F</gtr:id><gtr:title>Rare coding variants in the phospholipase D3 gene confer risk for Alzheimer's disease.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f5fd8a036b6ccf0bb9a8fec23f69321d"><gtr:id>f5fd8a036b6ccf0bb9a8fec23f69321d</gtr:id><gtr:otherNames>Cruchaga C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>pm_16201_21_24336208</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>955960FF-46AF-4B0C-BE99-B177C9EDD8DD</gtr:id><gtr:title>Identification of common variants associated with human hippocampal and intracranial volumes.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9e9f254d9d808af1a43ce46fce3a313e"><gtr:id>9e9f254d9d808af1a43ce46fce3a313e</gtr:id><gtr:otherNames>Stein JL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>pm_16043_23_22504417</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F6A4AEAA-ED8C-472D-AEBF-A14ED157794E</gtr:id><gtr:title>The HapMap: charting a course for genetic discovery in neurological diseases.</gtr:title><gtr:parentPublicationTitle>Archives of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8cdc37128f45833332c0ee457dd6ee0e"><gtr:id>8cdc37128f45833332c0ee457dd6ee0e</gtr:id><gtr:otherNames>Hardy J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0003-9942</gtr:issn><gtr:outcomeId>6010D8A15C2</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F7E9BE94-E26F-4C45-84BC-EF2444EA5385</gtr:id><gtr:title>Corrigendum to &amp;quot;Assessment of common variability and expression quantitative trait loci for genome-wide associations for progressive supranuclear palsy.&amp;quot; [Neurobiol. Aging 35 (2014) 1514.e1-1514.e12].</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b9daf1044ffaa78c220fa83b15b9c753"><gtr:id>b9daf1044ffaa78c220fa83b15b9c753</gtr:id><gtr:otherNames>Ferrari R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn><gtr:outcomeId>5aa460bec25910.37673749</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>69178092-CB3F-4DCE-B0B8-9464E87CD6BA</gtr:id><gtr:title>A blood-based gene expression and signaling pathway analysis to differentiate between high and low grade gliomas.</gtr:title><gtr:parentPublicationTitle>Oncology reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1165a7f7f9efa51ea3857408dbcbd4ab"><gtr:id>1165a7f7f9efa51ea3857408dbcbd4ab</gtr:id><gtr:otherNames>Ponnampalam SN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1021-335X</gtr:issn><gtr:outcomeId>5aa460bd7478b1.20881282</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>60AEC112-E9D9-4B78-8DD2-83E83BB799C6</gtr:id><gtr:title>Genome-wide association study of obsessive-compulsive disorder.</gtr:title><gtr:parentPublicationTitle>Molecular psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1dcf1f77d2e1df7ff7feb37ded9568a9"><gtr:id>1dcf1f77d2e1df7ff7feb37ded9568a9</gtr:id><gtr:otherNames>Stewart SE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1359-4184</gtr:issn><gtr:outcomeId>pm_16043_23_22889921</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B0E4B60F-98F9-4C7C-84A0-05B1DE7B6C0D</gtr:id><gtr:title>Glycoprotein IIb/IIIa inhibitor associated severe thrombocytopenia in patients with coronary artery disease: Clinical course and outcomes.</gtr:title><gtr:parentPublicationTitle>Platelets</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4d5ac2aae1f35c6c1c3bf75dd7ea554a"><gtr:id>4d5ac2aae1f35c6c1c3bf75dd7ea554a</gtr:id><gtr:otherNames>Viswanathan G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0953-7104</gtr:issn><gtr:outcomeId>pm-16043-21913813</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1A249DA1-8187-462B-BB15-3F821B63ADAD</gtr:id><gtr:title>Gain-of-function mutations in the phosphatidylserine synthase 1 (PTDSS1) gene cause Lenz-Majewski syndrome.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dfb8dbadbbf2d9563aa73063b105482c"><gtr:id>dfb8dbadbbf2d9563aa73063b105482c</gtr:id><gtr:otherNames>Sousa SB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>pm_16201_21_24241535</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>083B442D-1336-40E3-8FB5-ACF69FD93BEB</gtr:id><gtr:title>Gene expression changes with age in skin, adipose tissue, blood and brain.</gtr:title><gtr:parentPublicationTitle>Genome biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/090dbbc0432bfda4750a3ea381e6a5f5"><gtr:id>090dbbc0432bfda4750a3ea381e6a5f5</gtr:id><gtr:otherNames>Glass D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1474-7596</gtr:issn><gtr:outcomeId>5464d55b0c4cc9.36853445</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>01F0EEE2-E52D-414C-8847-F609ABF00BE1</gtr:id><gtr:title>Common variants at 12q14 and 12q24 are associated with hippocampal volume.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9bde7758d4db768ae0610c275fbb9a93"><gtr:id>9bde7758d4db768ae0610c275fbb9a93</gtr:id><gtr:otherNames>Bis JC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>pm_16043_23_22504421</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A93D894B-B7A9-494A-956A-1CBD4CE261D3</gtr:id><gtr:title>Insights into TREM2 biology by network analysis of human brain gene expression data.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/05229e5e9f0a501fa7e63a396d570040"><gtr:id>05229e5e9f0a501fa7e63a396d570040</gtr:id><gtr:otherNames>Forabosco P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn><gtr:outcomeId>pm_16201_21_23855984</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9EBCC41F-D55C-4CAA-A545-0755236C821A</gtr:id><gtr:title>The relationship between nosology, etiology and pathogenesis in neurodegenerative diseases.</gtr:title><gtr:parentPublicationTitle>Handbook of clinical neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8cdc37128f45833332c0ee457dd6ee0e"><gtr:id>8cdc37128f45833332c0ee457dd6ee0e</gtr:id><gtr:otherNames>Hardy J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0072-9752</gtr:issn><gtr:outcomeId>750D68C3E50</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0C9F79FF-98B8-4B07-A61A-E62E9A5299AC</gtr:id><gtr:title>The role of variation at A?PP, PSEN1, PSEN2, and MAPT in late onset Alzheimer's disease.</gtr:title><gtr:parentPublicationTitle>Journal of Alzheimer's disease : JAD</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/719950cfe57960088e8c4cb5aaf09b14"><gtr:id>719950cfe57960088e8c4cb5aaf09b14</gtr:id><gtr:otherNames>Gerrish A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1387-2877</gtr:issn><gtr:outcomeId>pm-16043-22027014</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FF955FAC-650C-4AFC-A9DD-955F7D269C20</gtr:id><gtr:title>Assessment of common variability and expression quantitative trait loci for genome-wide associations for progressive supranuclear palsy.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b9daf1044ffaa78c220fa83b15b9c753"><gtr:id>b9daf1044ffaa78c220fa83b15b9c753</gtr:id><gtr:otherNames>Ferrari R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn><gtr:outcomeId>pm_540e16de16d4748ed</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5D9AE405-EBCE-4BA9-96A0-BA2781532F12</gtr:id><gtr:title>Mendelian disorders and multifactorial traits: the big divide or one for all?</gtr:title><gtr:parentPublicationTitle>Nature reviews. Genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6df1b697ba220e5b3bd2403088f1e2fc"><gtr:id>6df1b697ba220e5b3bd2403088f1e2fc</gtr:id><gtr:otherNames>Antonarakis SE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1471-0056</gtr:issn><gtr:outcomeId>pm-16043-20395971</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>375B1B63-5785-4CCB-AFC4-C2FCEEC126AE</gtr:id><gtr:title>SCA15 due to large ITPR1 deletions in a cohort of 333 white families with dominant ataxia.</gtr:title><gtr:parentPublicationTitle>Archives of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b594e86c8f83338f89abfc465784f656"><gtr:id>b594e86c8f83338f89abfc465784f656</gtr:id><gtr:otherNames>Marelli C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0003-9942</gtr:issn><gtr:outcomeId>pm-16043-21555639</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5B0E834C-A942-40C0-9A18-A8070B54282F</gtr:id><gtr:title>Mutations in NKX6-2 Cause Progressive Spastic Ataxia and Hypomyelination.</gtr:title><gtr:parentPublicationTitle>American journal of human genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/034f6f958aa47e49cbb180fb10e1d728"><gtr:id>034f6f958aa47e49cbb180fb10e1d728</gtr:id><gtr:otherNames>Chelban V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0002-9297</gtr:issn><gtr:outcomeId>5aa460bc0f9c27.16562000</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>12E428B9-0739-4442-8B3B-F31E62CB6D06</gtr:id><gtr:title>A generalizable hypothesis for the genetic architecture of disease: pleomorphic risk loci.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c935c0efe5b22f529721363ec44ed6dd"><gtr:id>c935c0efe5b22f529721363ec44ed6dd</gtr:id><gtr:otherNames>Singleton A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>pm-16043-21875901</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CEF7D5CE-D32B-4ACB-BAAD-C8185137C71F</gtr:id><gtr:title>An additional k-means clustering step improves the biological features of WGCNA gene co-expression networks.</gtr:title><gtr:parentPublicationTitle>BMC systems biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6f2e53572e2ff4fe72075e7fe5504682"><gtr:id>6f2e53572e2ff4fe72075e7fe5504682</gtr:id><gtr:otherNames>Bot?a JA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1752-0509</gtr:issn><gtr:outcomeId>5a2fd75e77c373.67975784</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BA1710DB-0554-47E8-8FCE-2F1F81DD9020</gtr:id><gtr:title>Quality control parameters on a large dataset of regionally dissected human control brains for whole genome expression studies.</gtr:title><gtr:parentPublicationTitle>Journal of neurochemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0fc9b26a4f240104f4f5378597d75aff"><gtr:id>0fc9b26a4f240104f4f5378597d75aff</gtr:id><gtr:otherNames>Trabzuni D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0022-3042</gtr:issn><gtr:outcomeId>tkwMyYPvE4N</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8702A02A-0AB2-41E9-A32D-FE2146F5A224</gtr:id><gtr:title>The genetic architecture of Alzheimer's disease: beyond APP, PSENs and APOE.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f54cad0ab0877e543fc660186cd44ff0"><gtr:id>f54cad0ab0877e543fc660186cd44ff0</gtr:id><gtr:otherNames>Guerreiro RJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn><gtr:outcomeId>pm-16043-20594621</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>57F66300-936D-4CEF-B9C8-AF9EEB13F93D</gtr:id><gtr:title>Mutations in SNX14 cause a distinctive autosomal-recessive cerebellar ataxia and intellectual disability syndrome.</gtr:title><gtr:parentPublicationTitle>American journal of human genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a7dda45248e47eb0023a4ccbd6908c4e"><gtr:id>a7dda45248e47eb0023a4ccbd6908c4e</gtr:id><gtr:otherNames>Thomas AC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0002-9297</gtr:issn><gtr:outcomeId>548a02820506b3.37304518</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3430E118-2307-401F-8464-B3A79044F388</gtr:id><gtr:title>Serum iron levels and the risk of Parkinson disease: a Mendelian randomization study.</gtr:title><gtr:parentPublicationTitle>PLoS medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6d633de923aea18df03c8589daadc941"><gtr:id>6d633de923aea18df03c8589daadc941</gtr:id><gtr:otherNames>Pichler I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1549-1277</gtr:issn><gtr:outcomeId>pm_16201_21_23750121</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CF9078B1-19C5-4CDA-B20E-6ADD5687F337</gtr:id><gtr:title>The genetics of neurodegenerative diseases.</gtr:title><gtr:parentPublicationTitle>Journal of neurochemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8cdc37128f45833332c0ee457dd6ee0e"><gtr:id>8cdc37128f45833332c0ee457dd6ee0e</gtr:id><gtr:otherNames>Hardy J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0022-3042</gtr:issn><gtr:outcomeId>7930C367638</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CBC98A5C-C874-4DDC-9F42-4D25C3A888F1</gtr:id><gtr:title>A simple and efficient algorithm for genome-wide homozygosity analysis in disease.</gtr:title><gtr:parentPublicationTitle>Molecular systems biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c14bc14b523f46259b756e82875d7f82"><gtr:id>c14bc14b523f46259b756e82875d7f82</gtr:id><gtr:otherNames>Liu W</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1744-4292</gtr:issn><gtr:outcomeId>9F8C45FD036</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A200DD3B-956E-4F64-9353-B9D0F6D6F6DD</gtr:id><gtr:title>Structural brain abnormalities in the common epilepsies assessed in a worldwide ENIGMA study.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7a4311fe04f3886653bc42ccc6c878c3"><gtr:id>7a4311fe04f3886653bc42ccc6c878c3</gtr:id><gtr:otherNames>Whelan CD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>5aa460bc3e1523.34459437</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0D9F5CB8-CF47-4B04-89F9-39A711A872B4</gtr:id><gtr:title>Pathological relationships involving iron and myelin may constitute a shared mechanism linking various rare and common brain diseases.</gtr:title><gtr:parentPublicationTitle>Rare diseases (Austin, Tex.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b7db88df9f44c9c37b5e7c23fe5b4135"><gtr:id>b7db88df9f44c9c37b5e7c23fe5b4135</gtr:id><gtr:otherNames>Heidari M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2167-5511</gtr:issn><gtr:outcomeId>5aa460be9262d9.32754954</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C4851948-4B35-4BC8-9C81-4B00EEDEFCA1</gtr:id><gtr:title>A genome-wide association meta-analysis identifies a novel locus at 17q11.2 associated with sporadic amyotrophic lateral sclerosis.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/68ae0b5920edebc0579f77ebe7ddbb4e"><gtr:id>68ae0b5920edebc0579f77ebe7ddbb4e</gtr:id><gtr:otherNames>Fogh I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>5464d37d697656.62957385</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>00FD8922-2E1A-4367-AD3A-D0CF9DDA3C9A</gtr:id><gtr:title>Genome-wide association study of Tourette's syndrome.</gtr:title><gtr:parentPublicationTitle>Molecular psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/045c7ec333f69f0a159e3c0e5f7b66f6"><gtr:id>045c7ec333f69f0a159e3c0e5f7b66f6</gtr:id><gtr:otherNames>Scharf JM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1359-4184</gtr:issn><gtr:outcomeId>pm_16043_23_22889924</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>009AD49B-E277-45F7-A170-27606CE1CD7F</gtr:id><gtr:title>Biomarkers for Alzheimer's disease: academic, industry and regulatory perspectives.</gtr:title><gtr:parentPublicationTitle>Nature reviews. Drug discovery</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/62dd352243d69eac75146be22c5ef7bc"><gtr:id>62dd352243d69eac75146be22c5ef7bc</gtr:id><gtr:otherNames>Hampel H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1474-1776</gtr:issn><gtr:outcomeId>pm-16043-20592748</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0A65B50C-2651-4555-91F0-155FD6F6A10F</gtr:id><gtr:title>No evidence that extended tracts of homozygosity are associated with Alzheimer's disease.</gtr:title><gtr:parentPublicationTitle>American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9da89c318f56fc7256d9d74b60d23229"><gtr:id>9da89c318f56fc7256d9d74b60d23229</gtr:id><gtr:otherNames>Sims R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1552-4841</gtr:issn><gtr:outcomeId>pm-16043-21812096</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F0EE8211-6C9C-4DE2-95B1-DFA888FA2BEB</gtr:id><gtr:title>Age-associated changes in gene expression in human brain and isolated neurons.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1a93647d799d53d5111001b3b241fdab"><gtr:id>1a93647d799d53d5111001b3b241fdab</gtr:id><gtr:otherNames>Kumar A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn><gtr:outcomeId>pm_16043_23_23177596</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9FD53AAF-2C4A-4A8E-9344-A97DE2FE6B21</gtr:id><gtr:title>Discovery and functional prioritization of Parkinson's disease candidate genes from large-scale whole exome sequencing.</gtr:title><gtr:parentPublicationTitle>Genome biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/aac30b01b744525ffc7d06e70f2732d7"><gtr:id>aac30b01b744525ffc7d06e70f2732d7</gtr:id><gtr:otherNames>Jansen IE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1474-7596</gtr:issn><gtr:outcomeId>5aa460bd3c6655.62450532</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D70B8F89-6F71-4F50-8792-25D01629024A</gtr:id><gtr:title>Pathogenic LRRK2 mutations do not alter gene expression in cell model systems or human brain tissue.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/81b016b620411b3da51cfd468ebe3c2a"><gtr:id>81b016b620411b3da51cfd468ebe3c2a</gtr:id><gtr:otherNames>Devine MJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>Rm9XoEvNZoB</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BF088705-4E19-4250-B38D-2035BF8348F9</gtr:id><gtr:title>Neurological diagnoses identify molecular processes.</gtr:title><gtr:parentPublicationTitle>Archives of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8cdc37128f45833332c0ee457dd6ee0e"><gtr:id>8cdc37128f45833332c0ee457dd6ee0e</gtr:id><gtr:otherNames>Hardy J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0003-9942</gtr:issn><gtr:outcomeId>pm-16043-20385904</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2B10CDF9-95ED-44CD-AA24-C1EFFE4B0795</gtr:id><gtr:title>Genomic risk profiling of ischemic stroke: results of an international genome-wide association meta-analysis.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b2dca023d652f7093eda6bab049ee381"><gtr:id>b2dca023d652f7093eda6bab049ee381</gtr:id><gtr:otherNames>Meschia JF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm-16043-21957438</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F9F536E8-1126-451D-89BB-2774F42B8E5F</gtr:id><gtr:title>A loss-of-function homozygous mutation in DDX59 implicates a conserved DEAD-box RNA helicase in nervous system development and function.</gtr:title><gtr:parentPublicationTitle>Human mutation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c12954aa30a8fba72f3439d776bda00b"><gtr:id>c12954aa30a8fba72f3439d776bda00b</gtr:id><gtr:otherNames>Salpietro V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>1059-7794</gtr:issn><gtr:outcomeId>5aa460bc7820a1.05536374</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8DD0B9D0-E97D-469C-A1FF-EB965B8A9F64</gtr:id><gtr:title>Novel genetic loci underlying human intracranial volume identified through genome-wide association.</gtr:title><gtr:parentPublicationTitle>Nature neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6e2661c4e36c54a85ad324bac655b6bf"><gtr:id>6e2661c4e36c54a85ad324bac655b6bf</gtr:id><gtr:otherNames>Adams HH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1097-6256</gtr:issn><gtr:outcomeId>5aa460bdb03890.13981590</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4F1BB3D8-A6C9-4CEE-9D0D-291C5D30758E</gtr:id><gtr:title>Genotype, haplotype and copy-number variation in worldwide human populations.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/45e9d54aa3d1102bb6e3429ceb4d2c9d"><gtr:id>45e9d54aa3d1102bb6e3429ceb4d2c9d</gtr:id><gtr:otherNames>Jakobsson M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>60FB8C9CBBE</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AD1F40D8-F2E4-4C00-B4B9-D6FBBBE50839</gtr:id><gtr:title>Brain expression genome-wide association study (eGWAS) identifies human disease-associated variants.</gtr:title><gtr:parentPublicationTitle>PLoS genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f50f494061631e387b397ef9e7255462"><gtr:id>f50f494061631e387b397ef9e7255462</gtr:id><gtr:otherNames>Zou F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1553-7390</gtr:issn><gtr:outcomeId>pm_16043_23_22685416</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7ED52B4F-4D66-4ABE-BECC-FD90AE14ABDA</gtr:id><gtr:title>Insights from cerebellar transcriptomic analysis into the pathogenesis of ataxia.</gtr:title><gtr:parentPublicationTitle>JAMA neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9960cd808582e52821f0e586e2ba9176"><gtr:id>9960cd808582e52821f0e586e2ba9176</gtr:id><gtr:otherNames>Bettencourt C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2168-6149</gtr:issn><gtr:outcomeId>pm_540e166e166ed09c3</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A8C44F74-E160-45A0-B502-C966419C6849</gtr:id><gtr:title>Resolving the polymorphism-in-probe problem is critical for correct interpretation of expression QTL studies.</gtr:title><gtr:parentPublicationTitle>Nucleic acids research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/52571622ddf586543c15906e6485b96b"><gtr:id>52571622ddf586543c15906e6485b96b</gtr:id><gtr:otherNames>Ramasamy A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0305-1048</gtr:issn><gtr:outcomeId>546cbd7f4bf4e9.96240497</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>97C4EDE4-DEF0-481B-B990-5E8FDD3CFE36</gtr:id><gtr:title>Widespread sex differences in gene expression and splicing in the adult human brain.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0fc9b26a4f240104f4f5378597d75aff"><gtr:id>0fc9b26a4f240104f4f5378597d75aff</gtr:id><gtr:otherNames>Trabzuni D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn><gtr:outcomeId>pm_16201_21_24264146</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5D1D0BD1-849D-4B35-89E8-F6BDD591EB57</gtr:id><gtr:title>Genotypic analysis of gene expression in the dissection of the aetiology of complex neurological and psychiatric diseases.</gtr:title><gtr:parentPublicationTitle>Briefings in functional genomics &amp; proteomics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4a9b6473165343330890f076ccb90697"><gtr:id>4a9b6473165343330890f076ccb90697</gtr:id><gtr:otherNames>Ryten M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1473-9550</gtr:issn><gtr:outcomeId>DtjMzkpdRyc</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5DCF9D45-9442-41F0-90B3-0374FA97310A</gtr:id><gtr:title>MAPT expression and splicing is differentially regulated by brain region: relation to genotype and implication for tauopathies.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0fc9b26a4f240104f4f5378597d75aff"><gtr:id>0fc9b26a4f240104f4f5378597d75aff</gtr:id><gtr:otherNames>Trabzuni D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>pm_16043_23_22723018</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0651559A-BAF8-4E32-8E99-6560D5EFBCEB</gtr:id><gtr:title>Genomewide association studies and human disease.</gtr:title><gtr:parentPublicationTitle>The New England journal of medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8cdc37128f45833332c0ee457dd6ee0e"><gtr:id>8cdc37128f45833332c0ee457dd6ee0e</gtr:id><gtr:otherNames>Hardy J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0028-4793</gtr:issn><gtr:outcomeId>732E1885A8C</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F3445EBA-9343-4B34-A4DC-6ED8D847B8C0</gtr:id><gtr:title>Genotype-imputation accuracy across worldwide human populations.</gtr:title><gtr:parentPublicationTitle>American journal of human genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7ed86940955cce5cf2bf47cdad1d4746"><gtr:id>7ed86940955cce5cf2bf47cdad1d4746</gtr:id><gtr:otherNames>Huang L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0002-9297</gtr:issn><gtr:outcomeId>E231B7373CE</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>84E593A4-8A85-4CC1-8AA1-EAC2BFAB8143</gtr:id><gtr:title>A genome-wide association study implicates diacylglycerol kinase eta (DGKH) and several other genes in the etiology of bipolar disorder.</gtr:title><gtr:parentPublicationTitle>Molecular psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d64ef2b3011f39381d3cc81a2fb3a7c2"><gtr:id>d64ef2b3011f39381d3cc81a2fb3a7c2</gtr:id><gtr:otherNames>Baum AE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1359-4184</gtr:issn><gtr:outcomeId>E8FB002C9E0</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B8D258DE-BBB7-42BF-AF52-2D8B04F4F874</gtr:id><gtr:title>A two-stage meta-analysis identifies several new loci for Parkinson's disease.</gtr:title><gtr:parentPublicationTitle>PLoS genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/21954146dfa6bdef021f2fa27d03fd93"><gtr:id>21954146dfa6bdef021f2fa27d03fd93</gtr:id><gtr:otherNames>International Parkinson's Disease Genomics Consortium (IPDGC)</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1553-7390</gtr:issn><gtr:outcomeId>mxLBFYchi1h</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B9CB551B-FFB4-4C3D-8F8D-55DCB0C39B7C</gtr:id><gtr:title>Using genome-wide complex trait analysis to quantify 'missing heritability' in Parkinson's disease.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5ed587de899b30ad5f3dce3fc99e9d0a"><gtr:id>5ed587de899b30ad5f3dce3fc99e9d0a</gtr:id><gtr:otherNames>Keller MF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>pm_16043_23_22892372</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7CE7B2C2-0CB2-4B03-A4FD-BA7EF197BEB2</gtr:id><gtr:title>Genetic variants influencing human aging from late-onset Alzheimer's disease (LOAD) genome-wide association studies (GWAS).</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9a2c27e62e42f495e188725f3e1be5c4"><gtr:id>9a2c27e62e42f495e188725f3e1be5c4</gtr:id><gtr:otherNames>Shi H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn><gtr:outcomeId>pm_16043_23_22445811</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3CD039F2-AC56-41E4-97E0-0DF1F9D96724</gtr:id><gtr:title>An additional k-means clustering step improves the biological features of WGCNA gene co-expression networks.</gtr:title><gtr:parentPublicationTitle>BMC systems biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6f2e53572e2ff4fe72075e7fe5504682"><gtr:id>6f2e53572e2ff4fe72075e7fe5504682</gtr:id><gtr:otherNames>Bot?a JA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1752-0509</gtr:issn><gtr:outcomeId>5aa460bcb110c8.97557276</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>651B3FF6-3E28-46DD-9614-0FFC0F2E34AE</gtr:id><gtr:title>Protected to death.</gtr:title><gtr:parentPublicationTitle>Journal of Alzheimer's disease : JAD</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8cdc37128f45833332c0ee457dd6ee0e"><gtr:id>8cdc37128f45833332c0ee457dd6ee0e</gtr:id><gtr:otherNames>Hardy J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1387-2877</gtr:issn><gtr:outcomeId>pm-16043-20182050</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>41E1939A-77C5-447A-AFC0-A4CD382F3954</gtr:id><gtr:title>A new way APP mismetabolism can lead to Alzheimer's disease.</gtr:title><gtr:parentPublicationTitle>EMBO molecular medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8cdc37128f45833332c0ee457dd6ee0e"><gtr:id>8cdc37128f45833332c0ee457dd6ee0e</gtr:id><gtr:otherNames>Hardy J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1757-4676</gtr:issn><gtr:outcomeId>pm-16043-21523909</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F18CFF34-3C99-436A-BB9F-65846A5FBD85</gtr:id><gtr:title>NeuroChip, an updated version of the NeuroX genotyping platform to rapidly screen for variants associated with neurological diseases.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5c548daa91b19b3ab5594f4482ec73e2"><gtr:id>5c548daa91b19b3ab5594f4482ec73e2</gtr:id><gtr:otherNames>Blauwendraat C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn><gtr:outcomeId>5aa460bb66aed1.77687925</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>93DF1F6D-C977-4E84-BAA1-746E0040D251</gtr:id><gtr:title>Cross-disorder genome-wide analyses suggest a complex genetic relationship between Tourette's syndrome and OCD.</gtr:title><gtr:parentPublicationTitle>The American journal of psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/547f807dc0ebfcdc83f554f5aca958ab"><gtr:id>547f807dc0ebfcdc83f554f5aca958ab</gtr:id><gtr:otherNames>Yu D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0002-953X</gtr:issn><gtr:outcomeId>5464d37e97a7e3.05507537</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C59BAB10-063A-424F-A29A-CBEEA55E6486</gtr:id><gtr:title>Novel genetic loci associated with hippocampal volume.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1ef1639d3dafba8a52010bd7ff024e81"><gtr:id>1ef1639d3dafba8a52010bd7ff024e81</gtr:id><gtr:otherNames>Hibar DP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn><gtr:outcomeId>5aa460bd02a643.66028803</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5B509E22-7982-47F6-AC31-CF8949EDD340</gtr:id><gtr:title>Fine-mapping, gene expression and splicing analysis of the disease associated LRRK2 locus.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0fc9b26a4f240104f4f5378597d75aff"><gtr:id>0fc9b26a4f240104f4f5378597d75aff</gtr:id><gtr:otherNames>Trabzuni D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>5464d55b30cb19.25530905</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MR/K01417X/1</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>041997EB-CFD8-493D-B0F8-DFA35451D0BE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Neurological</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>